COMPOSITIONS AND METHODS FOR TREATING DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION

Abstract The present invention relates to an oral pharmaceutical composition, comprising a plurality of xanomeline beads having a core comprising xanomeline or a salt thereof; and a plurality of trospium beads having a core comprising a salt of trospium.

Saved in:
Bibliographic Details
Main Authors REHLAENDER, Bruce, BETANCOURT, Aimesther, THIBERT, Roch
Format Patent
LanguageEnglish
Published 29.09.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract The present invention relates to an oral pharmaceutical composition, comprising a plurality of xanomeline beads having a core comprising xanomeline or a salt thereof; and a plurality of trospium beads having a core comprising a salt of trospium.
Bibliography:Application Number: AU20220224813